Metabolites
Displaying compounds 14351 - 14375 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB13372 | Lyso-PS(0:0/20:4(5Z,8Z,11Z,14Z)) | 2-azaniumyl-3-({3-hydroxy-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propyl phosphono}oxy)propanoate | C26H43NO9P 544.602 |  |
| YMDB13338 | Lyso-PI(14:0/0:0) | [2-hydroxy-3-(tetradecanoyloxy)propoxy][(2,3,4,5,6-pentahydroxycyclohexyl)oxy]phosphinic acid | C23H45O12P 544.575 |  |
| YMDB13347 | Lyso-PI(0:0/14:0) | [3-hydroxy-2-(tetradecanoyloxy)propoxy][(2,3,4,5,6-pentahydroxycyclohexyl)oxy]phosphinic acid | C23H45O12P 544.575 |  |
| YMDB01223 | PI(14:0/0:0) | [(2R)-2-hydroxy-3-(tetradecanoyloxy)propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid | C23H45O12P 544.57 |  |
| YMDB13318 | Lyso-PC(20:4(5Z,8Z,11Z,14Z)/0:0) | {2-[({2-hydroxy-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propoxy}(-lambda3-oxidanidylidene)oxido-lambda5-phosphanyl)oxy]ethyl}trimethylazanium | C28H50NO7P 543.682 |  |
| YMDB02213 | LysoPC(20:4(5Z,8Z,11Z,14Z)) | (2-{[(2R)-2-hydroxy-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium | C28H50NO7P 543.6729 |  |
| YMDB02214 | LysoPC(20:4(8Z,11Z,14Z,17Z)) | (2-{[(2R)-2-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium | C28H50NO7P 543.6729 |  |
| YMDB01229 | PI(14:1(9Z)/0:0) | [(2R)-2-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid | C23H43O12P 542.5541 |  |
| YMDB16161 | CE(10:0) | 2,15-dimethyl-14-(6-methylheptan-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl decanoate | C37H64O2 540.9029 |  |
| YMDB01124 | DG(14:0/16:0/0:0) | (2R)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl hexadecanoate | C33H64O5 540.87 |  |
| YMDB12689 | DG(10:0/20:0/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl icosanoate | C33H64O5 540.87 |  |
| YMDB12716 | DG(12:0/18:0/0:0) | (2R)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl octadecanoate | C33H64O5 540.87 |  |
| YMDB12816 | DG(15:0/15:0/0:0) | (2R)-1-hydroxy-3-(pentadecanoyloxy)propan-2-yl pentadecanoate | C33H64O5 540.87 |  |
| YMDB01125 | DG(14:0/16:1(9Z)/0:0) 3738-74-7 | (2R)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (9Z)-hexadec-9-enoate | C33H62O5 538.854 |  |
| YMDB12690 | DG(10:0/20:1(11Z)/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl (11Z)-icos-11-enoate | C33H62O5 538.854 |  |
| YMDB12691 | DG(10:0/20:1(13Z)/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl (13Z)-icos-13-enoate | C33H62O5 538.854 |  |
| YMDB12717 | DG(12:0/18:1(11Z)/0:0) | (2R)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl (11Z)-octadec-11-enoate | C33H62O5 538.854 |  |
| YMDB12718 | DG(12:0/18:1(9Z)/0:0) | (2R)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl (9Z)-octadec-9-enoate | C33H62O5 538.854 |  |
| YMDB12743 | DG(14:0/16:1(11Z)/0:0) | (2R)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (11Z)-hexadec-11-enoate | C33H62O5 538.854 |  |
| YMDB12768 | DG(14:1(11Z)/16:0/0:0) | (2R)-1-hydroxy-3-[(11Z)-tetradec-11-enoyloxy]propan-2-yl hexadecanoate | C33H62O5 538.854 |  |
| YMDB12795 | DG(14:1(9Z)/16:0/0:0) | (2R)-1-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl hexadecanoate | C33H62O5 538.854 |  |
| YMDB12817 | DG(15:0/15:1(11Z)/0:0) | (2R)-1-hydroxy-3-(pentadecanoyloxy)propan-2-yl (11Z)-pentadec-11-enoate | C33H62O5 538.854 |  |
| YMDB12818 | DG(15:0/15:1(9Z)/0:0) | (2R)-1-hydroxy-3-(pentadecanoyloxy)propan-2-yl (9Z)-pentadec-9-enoate | C33H62O5 538.854 |  |
| YMDB13852 | PE-NMe(10:0/10:0) | [2,3-bis(decanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid | C26H52NO8P 537.675 |  |
| YMDB00867 | CDP-ribitol 3506-17-0 | {[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[hydroxy({[(2R,3S,4S)-2,3,4,5-tetrahydroxypentyl]oxy})phosphoryl]oxy})phosphinic acid | C14H25N3O15P2 537.3069 |  |